303 related articles for article (PubMed ID: 29724786)
1. Autism-associated neuroligin-4 mutation selectively impairs glycinergic synaptic transmission in mouse brainstem synapses.
Zhang B; Gokce O; Hale WD; Brose N; Südhof TC
J Exp Med; 2018 Jun; 215(6):1543-1553. PubMed ID: 29724786
[TBL] [Abstract][Full Text] [Related]
2. Unique versus Redundant Functions of Neuroligin Genes in Shaping Excitatory and Inhibitory Synapse Properties.
Chanda S; Hale WD; Zhang B; Wernig M; Südhof TC
J Neurosci; 2017 Jul; 37(29):6816-6836. PubMed ID: 28607166
[TBL] [Abstract][Full Text] [Related]
3. Developmental plasticity shapes synaptic phenotypes of autism-associated neuroligin-3 mutations in the calyx of Held.
Zhang B; Seigneur E; Wei P; Gokce O; Morgan J; Südhof TC
Mol Psychiatry; 2017 Oct; 22(10):1483-1491. PubMed ID: 27725662
[TBL] [Abstract][Full Text] [Related]
4. Neuroligins, synapse balance and neuropsychiatric disorders.
Maćkowiak M; Mordalska P; Wędzony K
Pharmacol Rep; 2014 Oct; 66(5):830-5. PubMed ID: 25149987
[TBL] [Abstract][Full Text] [Related]
5. An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons.
Cast TP; Boesch DJ; Smyth K; Shaw AE; Ghebrial M; Chanda S
J Neurosci; 2021 Jan; 41(3):392-407. PubMed ID: 33268543
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic mechanism of an autism-associated neuroligin mutation involves altered AMPA-receptor trafficking.
Chanda S; Aoto J; Lee SJ; Wernig M; Südhof TC
Mol Psychiatry; 2016 Feb; 21(2):169-77. PubMed ID: 25778475
[TBL] [Abstract][Full Text] [Related]
7. Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons.
Marro SG; Chanda S; Yang N; Janas JA; Valperga G; Trotter J; Zhou B; Merrill S; Yousif I; Shelby H; Vogel H; Kalani MYS; Südhof TC; Wernig M
Neuron; 2019 Aug; 103(4):617-626.e6. PubMed ID: 31257103
[TBL] [Abstract][Full Text] [Related]
8. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus.
Etherton MR; Tabuchi K; Sharma M; Ko J; Südhof TC
EMBO J; 2011 Jun; 30(14):2908-19. PubMed ID: 21642956
[TBL] [Abstract][Full Text] [Related]
9. Neuroligins Are Selectively Essential for NMDAR Signaling in Cerebellar Stellate Interneurons.
Zhang B; Südhof TC
J Neurosci; 2016 Aug; 36(35):9070-83. PubMed ID: 27581450
[TBL] [Abstract][Full Text] [Related]
10. SPARCL1 Promotes Excitatory But Not Inhibitory Synapse Formation and Function Independent of Neurexins and Neuroligins.
Gan KJ; Südhof TC
J Neurosci; 2020 Oct; 40(42):8088-8102. PubMed ID: 32973045
[TBL] [Abstract][Full Text] [Related]
11. Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.
Hammer M; Krueger-Burg D; Tuffy LP; Cooper BH; Taschenberger H; Goswami SP; Ehrenreich H; Jonas P; Varoqueaux F; Rhee JS; Brose N
Cell Rep; 2015 Oct; 13(3):516-523. PubMed ID: 26456829
[TBL] [Abstract][Full Text] [Related]
12. Autism-associated mutation inhibits protein kinase C-mediated neuroligin-4X enhancement of excitatory synapses.
Bemben MA; Nguyen QA; Wang T; Li Y; Nicoll RA; Roche KW
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2551-6. PubMed ID: 25675530
[TBL] [Abstract][Full Text] [Related]
13. Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.
Chubykin AA; Atasoy D; Etherton MR; Brose N; Kavalali ET; Gibson JR; Südhof TC
Neuron; 2007 Jun; 54(6):919-31. PubMed ID: 17582332
[TBL] [Abstract][Full Text] [Related]
14. Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-autonomous NMDA receptor-independent mechanism.
Jiang M; Polepalli J; Chen LY; Zhang B; Südhof TC; Malenka RC
Mol Psychiatry; 2017 Mar; 22(3):375-383. PubMed ID: 27217145
[TBL] [Abstract][Full Text] [Related]
15. Neurexins control the strength and precise timing of glycinergic inhibition in the auditory brainstem.
Jiang HH; Xu R; Nie X; Su Z; Xu X; Pang R; Zhou Y; Luo F
Elife; 2024 May; 13():. PubMed ID: 38814174
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles for extracellular and intracellular domains in neuroligin function at inhibitory synapses.
Nguyen QA; Horn ME; Nicoll RA
Elife; 2016 Nov; 5():. PubMed ID: 27805570
[TBL] [Abstract][Full Text] [Related]
17. Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling.
Speed HE; Masiulis I; Gibson JR; Powell CM
PLoS One; 2015; 10(10):e0140638. PubMed ID: 26469287
[TBL] [Abstract][Full Text] [Related]
18. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice.
Tabuchi K; Blundell J; Etherton MR; Hammer RE; Liu X; Powell CM; Südhof TC
Science; 2007 Oct; 318(5847):71-6. PubMed ID: 17823315
[TBL] [Abstract][Full Text] [Related]
19. Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism.
Chubykin AA; Liu X; Comoletti D; Tsigelny I; Taylor P; Südhof TC
J Biol Chem; 2005 Jun; 280(23):22365-74. PubMed ID: 15797875
[TBL] [Abstract][Full Text] [Related]
20. Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling.
Földy C; Malenka RC; Südhof TC
Neuron; 2013 May; 78(3):498-509. PubMed ID: 23583622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
